Post hoc analysis of a phase 3, multicenter, open‐label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications

OBJECTIVE: To report post hoc results on how adjustments to baseline antiseizure medications (ASMs) in a subset of study sites (10 US sites) from a long‐term, open‐label phase 3 study of adjunctive cenobamate affected tolerability, efficacy, and retention. METHODS: Patients with uncontrolled focal s...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenfeld, William E., Abou‐Khalil, Bassel, Aboumatar, Sami, Bhatia, Perminder, Biton, Victor, Krauss, Gregory L., Sperling, Michael R., Vossler, David G., Klein, Pavel, Wechsler, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Full‐length Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292883/
https://www.ncbi.nlm.nih.gov/pubmed/34633074
http://dx.doi.org/10.1111/epi.17092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292883/
https://www.ncbi.nlm.nih.gov/pubmed/34633074
http://dx.doi.org/10.1111/epi.17092

Ejemplares similares